i-Drops DECONGESTANT EYE DROPS

Manufacturer
GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED
Effective date
2021-03-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 22:48:06

Label at a glance#

Producti-Drops DECONGESTANT EYE DROPS
Active ingredientGLYCERIN, NAPHAZOLINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

• For the relief of redness of the eye due to minor eye irritations • For the temporary relief of burning and irritation due to dryness of the eye • For use as a protectant against further irritation or dryness of the eye

Dosage and administration

Instill 1 or 2 drops in the affected eye(s) up to four times daily.

Storage and handling

• Store at room temperature • Remove contact lenses before using. • Tamper Evident: Do not use this product if neckband is missing or broken

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Glycerin 0.5%
Naphazoline hydrochloride 0.03%

PURPOSE

OTC - PURPOSE SECTION

Lubricant
Redness reliever

Uses

INDICATIONS & USAGE SECTION

• For the relief of redness of the eye due to minor eye irritations

• For the temporary relief of burning and irritation due to dryness of the eye

• For use as a protectant against further irritation or dryness of the eye

Warnings

WARNINGS SECTION

For external use only

Do not use if solution changes color or becomes cloudy

Ask a doctor before use if you have narrow angle glaucoma

When using this product
• To avoid contamination, do not touch tip of container to any surface
• Replace cap after using
• Overuse may produce increased redness of the eye
• Pupils may become enlarged temporarily

Stop use and ask a doctor if
• You experience eye pain
• You experience changes in vision
• You experience continued redness or irritation of the eye
• The condition worsens or persists for more than 72 hours

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center.

Directions

DOSAGE & ADMINISTRATION SECTION

Instill 1 or 2 drops in the affected eye(s) up to four times daily.

Other information

STORAGE AND HANDLING SECTION

• Store at room temperature

• Remove contact lenses before using.

• Tamper Evident: Do not use this product if neckband is missing or broken

Inactive ingredients

INACTIVE INGREDIENT SECTION

Benzalkonium chloride, Boric acid, Edetate disodium, Purified water, Sodium borate.

Questions?

OTC - QUESTIONS SECTION

Call toll-free 1-800-572-6632, weekdays, 7:00 AM - 5:30 PM EST.

SPL UNCLASSIFIED SECTION

• Eye Allergy Relief

• Soothes puffy itchy / red watering eyes

Manufactured by :

Global Pharma Healthcare Pvt. Ltd.,

A-9, SIDCO Pharmaceutical Complex,

Alathur-603 110 - INDIA.

www.global-pharma.com

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Decongestant-008Decongestant-008

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
73921-008-152023-02-08C16284748780-1f386c64a-159a-0266-e053-dadaa90a7c1ai-Drops DECONGESTANT EYE DROPS
73921-008-152023-01-30C16284748780-1f386c64a-159a-0266-e053-dadaa90a7c1ai-Drops DECONGESTANT EYE DROPS

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73921-00873921-008-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f42b6382-058d-0e63-e053-2a95a90a211c64a323d2-6c68-4165-8f3b-fa03b919b2472023-02-08WarningsExact identifier
spl set id: 64a323d2-6c68-4165-8f3b-fa03b919b247

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.